Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MRT-5410 by Sanofi for Unspecified Influenza Virus Infections: Likelihood of Approval
MRT-5410 is under clinical development by Sanofi and currently in Phase II for Unspecified Influenza Virus Infections. According to GlobalData,...